カテゴリー： Market Monitor Global, 世界, 医療/バイオ

アレルギー&副鼻腔炎薬の世界市場見通し2023年-2029年

◆英語タイトル：Allergy and Sinus Medicine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5639）

◆商品コード：MMG23JU5639
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：110
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Allergy and Sinus Medicine Market 調査レポートは次の情報を含め、グローバルにおけるのアレルギー&副鼻腔炎薬市場規模と予測を収録しています。・世界のアレルギー&副鼻腔炎薬市場：売上、2018年-2023年、2024年-2029年
・世界のアレルギー&副鼻腔炎薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のアレルギー&副鼻腔炎薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「カプセル」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

アレルギー&副鼻腔炎薬のグローバル主要企業は、Libido-Max、 AZO、 Extenze、 Sudafed、 Johnson & Johnson (TYLENOL)、 H-E-B、 Breathe Right、 Kirkland Signature、 Allegra、 Claritin、 Flonase、 Benadryl、 TexaClear、 Xyzal、 Zyrtecなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、アレルギー&副鼻腔炎薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のアレルギー&副鼻腔炎薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のアレルギー&副鼻腔炎薬市場：タイプ別市場シェア、2022年
・カプセル、スプレー、液体、錠剤、その他

世界のアレルギー&副鼻腔炎薬市場：用途別、2018年-2023年、2024年-2029年
世界のアレルギー&副鼻腔炎薬市場：用途別市場シェア、2022年
・オンライン、オフライン

世界のアレルギー&副鼻腔炎薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のアレルギー&副鼻腔炎薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるアレルギー&副鼻腔炎薬のグローバル売上、2018年-2023年
・主要企業におけるアレルギー&副鼻腔炎薬のグローバル売上シェア、2022年
・主要企業におけるアレルギー&副鼻腔炎薬のグローバル販売量、2018年-2023年
・主要企業におけるアレルギー&副鼻腔炎薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Libido-Max、 AZO、 Extenze、 Sudafed、 Johnson & Johnson (TYLENOL)、 H-E-B、 Breathe Right、 Kirkland Signature、 Allegra、 Claritin、 Flonase、 Benadryl、 TexaClear、 Xyzal、 Zyrtec

*************************************************************

・調査・分析レポートの概要
アレルギー&副鼻腔炎薬市場の定義
市場セグメント
世界のアレルギー&副鼻腔炎薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のアレルギー&副鼻腔炎薬市場規模
世界のアレルギー&副鼻腔炎薬市場規模：2022年 VS 2029年
世界のアレルギー&副鼻腔炎薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのアレルギー&副鼻腔炎薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のアレルギー&副鼻腔炎薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：カプセル、スプレー、液体、錠剤、その他
アレルギー&副鼻腔炎薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：オンライン、オフライン
アレルギー&副鼻腔炎薬の用途別グローバル売上・予測

・地域別市場分析
地域別アレルギー&副鼻腔炎薬市場規模 2022年と2029年
地域別アレルギー&副鼻腔炎薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Libido-Max、 AZO、 Extenze、 Sudafed、 Johnson & Johnson (TYLENOL)、 H-E-B、 Breathe Right、 Kirkland Signature、 Allegra、 Claritin、 Flonase、 Benadryl、 TexaClear、 Xyzal、 Zyrtec
...

This report aims to provide a comprehensive presentation of the global market for Allergy and Sinus Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy and Sinus Medicine. This report contains market size and forecasts of Allergy and Sinus Medicine in global, including the following market information:
Global Allergy and Sinus Medicine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Allergy and Sinus Medicine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Allergy and Sinus Medicine companies in 2022 (%)
The global Allergy and Sinus Medicine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Capsule Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Allergy and Sinus Medicine include Libido-Max, AZO, Extenze, Sudafed, Johnson & Johnson (TYLENOL), H-E-B, Breathe Right, Kirkland Signature and Allegra, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Allergy and Sinus Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Allergy and Sinus Medicine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Allergy and Sinus Medicine Market Segment Percentages, by Type, 2022 (%)
Capsule
Spray
Liquid
Tablet
Others
Global Allergy and Sinus Medicine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Allergy and Sinus Medicine Market Segment Percentages, by Application, 2022 (%)
Online
Offline
Global Allergy and Sinus Medicine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Allergy and Sinus Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Allergy and Sinus Medicine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Allergy and Sinus Medicine revenues share in global market, 2022 (%)
Key companies Allergy and Sinus Medicine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Allergy and Sinus Medicine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Libido-Max
AZO
Extenze
Sudafed
Johnson & Johnson (TYLENOL)
H-E-B
Breathe Right
Kirkland Signature
Allegra
Claritin
Flonase
Benadryl
TexaClear
Xyzal
Zyrtec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Allergy and Sinus Medicine, market overview.
Chapter 2: Global Allergy and Sinus Medicine market size in revenue and volume.
Chapter 3: Detailed analysis of Allergy and Sinus Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Allergy and Sinus Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Allergy and Sinus Medicine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Allergy and Sinus Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Allergy and Sinus Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Allergy and Sinus Medicine Overall Market Size
2.1 Global Allergy and Sinus Medicine Market Size: 2022 VS 2029
2.2 Global Allergy and Sinus Medicine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Allergy and Sinus Medicine Sales: 2018-2029
3 Company Landscape
3.1 Top Allergy and Sinus Medicine Players in Global Market
3.2 Top Global Allergy and Sinus Medicine Companies Ranked by Revenue
3.3 Global Allergy and Sinus Medicine Revenue by Companies
3.4 Global Allergy and Sinus Medicine Sales by Companies
3.5 Global Allergy and Sinus Medicine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Allergy and Sinus Medicine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Allergy and Sinus Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Allergy and Sinus Medicine Players in Global Market
3.8.1 List of Global Tier 1 Allergy and Sinus Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Allergy and Sinus Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Allergy and Sinus Medicine Market Size Markets, 2022 & 2029
4.1.2 Capsule
4.1.3 Spray
4.1.4 Liquid
4.1.5 Tablet
4.1.6 Others
4.2 By Type – Global Allergy and Sinus Medicine Revenue & Forecasts
4.2.1 By Type – Global Allergy and Sinus Medicine Revenue, 2018-2023
4.2.2 By Type – Global Allergy and Sinus Medicine Revenue, 2024-2029
4.2.3 By Type – Global Allergy and Sinus Medicine Revenue Market Share, 2018-2029
4.3 By Type – Global Allergy and Sinus Medicine Sales & Forecasts
4.3.1 By Type – Global Allergy and Sinus Medicine Sales, 2018-2023
4.3.2 By Type – Global Allergy and Sinus Medicine Sales, 2024-2029
4.3.3 By Type – Global Allergy and Sinus Medicine Sales Market Share, 2018-2029
4.4 By Type – Global Allergy and Sinus Medicine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Allergy and Sinus Medicine Market Size, 2022 & 2029
5.1.2 Online
5.1.3 Offline
5.2 By Application – Global Allergy and Sinus Medicine Revenue & Forecasts
5.2.1 By Application – Global Allergy and Sinus Medicine Revenue, 2018-2023
5.2.2 By Application – Global Allergy and Sinus Medicine Revenue, 2024-2029
5.2.3 By Application – Global Allergy and Sinus Medicine Revenue Market Share, 2018-2029
5.3 By Application – Global Allergy and Sinus Medicine Sales & Forecasts
5.3.1 By Application – Global Allergy and Sinus Medicine Sales, 2018-2023
5.3.2 By Application – Global Allergy and Sinus Medicine Sales, 2024-2029
5.3.3 By Application – Global Allergy and Sinus Medicine Sales Market Share, 2018-2029
5.4 By Application – Global Allergy and Sinus Medicine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Allergy and Sinus Medicine Market Size, 2022 & 2029
6.2 By Region – Global Allergy and Sinus Medicine Revenue & Forecasts
6.2.1 By Region – Global Allergy and Sinus Medicine Revenue, 2018-2023
6.2.2 By Region – Global Allergy and Sinus Medicine Revenue, 2024-2029
6.2.3 By Region – Global Allergy and Sinus Medicine Revenue Market Share, 2018-2029
6.3 By Region – Global Allergy and Sinus Medicine Sales & Forecasts
6.3.1 By Region – Global Allergy and Sinus Medicine Sales, 2018-2023
6.3.2 By Region – Global Allergy and Sinus Medicine Sales, 2024-2029
6.3.3 By Region – Global Allergy and Sinus Medicine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Allergy and Sinus Medicine Revenue, 2018-2029
6.4.2 By Country – North America Allergy and Sinus Medicine Sales, 2018-2029
6.4.3 US Allergy and Sinus Medicine Market Size, 2018-2029
6.4.4 Canada Allergy and Sinus Medicine Market Size, 2018-2029
6.4.5 Mexico Allergy and Sinus Medicine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Allergy and Sinus Medicine Revenue, 2018-2029
6.5.2 By Country – Europe Allergy and Sinus Medicine Sales, 2018-2029
6.5.3 Germany Allergy and Sinus Medicine Market Size, 2018-2029
6.5.4 France Allergy and Sinus Medicine Market Size, 2018-2029
6.5.5 U.K. Allergy and Sinus Medicine Market Size, 2018-2029
6.5.6 Italy Allergy and Sinus Medicine Market Size, 2018-2029
6.5.7 Russia Allergy and Sinus Medicine Market Size, 2018-2029
6.5.8 Nordic Countries Allergy and Sinus Medicine Market Size, 2018-2029
6.5.9 Benelux Allergy and Sinus Medicine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Allergy and Sinus Medicine Revenue, 2018-2029
6.6.2 By Region – Asia Allergy and Sinus Medicine Sales, 2018-2029
6.6.3 China Allergy and Sinus Medicine Market Size, 2018-2029
6.6.4 Japan Allergy and Sinus Medicine Market Size, 2018-2029
6.6.5 South Korea Allergy and Sinus Medicine Market Size, 2018-2029
6.6.6 Southeast Asia Allergy and Sinus Medicine Market Size, 2018-2029
6.6.7 India Allergy and Sinus Medicine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Allergy and Sinus Medicine Revenue, 2018-2029
6.7.2 By Country – South America Allergy and Sinus Medicine Sales, 2018-2029
6.7.3 Brazil Allergy and Sinus Medicine Market Size, 2018-2029
6.7.4 Argentina Allergy and Sinus Medicine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Allergy and Sinus Medicine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Allergy and Sinus Medicine Sales, 2018-2029
6.8.3 Turkey Allergy and Sinus Medicine Market Size, 2018-2029
6.8.4 Israel Allergy and Sinus Medicine Market Size, 2018-2029
6.8.5 Saudi Arabia Allergy and Sinus Medicine Market Size, 2018-2029
6.8.6 UAE Allergy and Sinus Medicine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Libido-Max
7.1.1 Libido-Max Company Summary
7.1.2 Libido-Max Business Overview
7.1.3 Libido-Max Allergy and Sinus Medicine Major Product Offerings
7.1.4 Libido-Max Allergy and Sinus Medicine Sales and Revenue in Global (2018-2023)
7.1.5 Libido-Max Key News & Latest Developments
7.2 AZO
7.2.1 AZO Company Summary
7.2.2 AZO Business Overview
7.2.3 AZO Allergy and Sinus Medicine Major Product Offerings
7.2.4 AZO Allergy and Sinus Medicine Sales and Revenue in Global (2018-2023)
7.2.5 AZO Key News & Latest Developments
7.3 Extenze
7.3.1 Extenze Company Summary
7.3.2 Extenze Business Overview
7.3.3 Extenze Allergy and Sinus Medicine Major Product Offerings
7.3.4 Extenze Allergy and Sinus Medicine Sales and Revenue in Global (2018-2023)
7.3.5 Extenze Key News & Latest Developments
7.4 Sudafed
7.4.1 Sudafed Company Summary
7.4.2 Sudafed Business Overview
7.4.3 Sudafed Allergy and Sinus Medicine Major Product Offerings
7.4.4 Sudafed Allergy and Sinus Medicine Sales and Revenue in Global (2018-2023)
7.4.5 Sudafed Key News & Latest Developments
7.5 Johnson & Johnson (TYLENOL)
7.5.1 Johnson & Johnson (TYLENOL) Company Summary
7.5.2 Johnson & Johnson (TYLENOL) Business Overview
7.5.3 Johnson & Johnson (TYLENOL) Allergy and Sinus Medicine Major Product Offerings
7.5.4 Johnson & Johnson (TYLENOL) Allergy and Sinus Medicine Sales and Revenue in Global (2018-2023)
7.5.5 Johnson & Johnson (TYLENOL) Key News & Latest Developments
7.6 H-E-B
7.6.1 H-E-B Company Summary
7.6.2 H-E-B Business Overview
7.6.3 H-E-B Allergy and Sinus Medicine Major Product Offerings
7.6.4 H-E-B Allergy and Sinus Medicine Sales and Revenue in Global (2018-2023)
7.6.5 H-E-B Key News & Latest Developments
7.7 Breathe Right
7.7.1 Breathe Right Company Summary
7.7.2 Breathe Right Business Overview
7.7.3 Breathe Right Allergy and Sinus Medicine Major Product Offerings
7.7.4 Breathe Right Allergy and Sinus Medicine Sales and Revenue in Global (2018-2023)
7.7.5 Breathe Right Key News & Latest Developments
7.8 Kirkland Signature
7.8.1 Kirkland Signature Company Summary
7.8.2 Kirkland Signature Business Overview
7.8.3 Kirkland Signature Allergy and Sinus Medicine Major Product Offerings
7.8.4 Kirkland Signature Allergy and Sinus Medicine Sales and Revenue in Global (2018-2023)
7.8.5 Kirkland Signature Key News & Latest Developments
7.9 Allegra
7.9.1 Allegra Company Summary
7.9.2 Allegra Business Overview
7.9.3 Allegra Allergy and Sinus Medicine Major Product Offerings
7.9.4 Allegra Allergy and Sinus Medicine Sales and Revenue in Global (2018-2023)
7.9.5 Allegra Key News & Latest Developments
7.10 Claritin
7.10.1 Claritin Company Summary
7.10.2 Claritin Business Overview
7.10.3 Claritin Allergy and Sinus Medicine Major Product Offerings
7.10.4 Claritin Allergy and Sinus Medicine Sales and Revenue in Global (2018-2023)
7.10.5 Claritin Key News & Latest Developments
7.11 Flonase
7.11.1 Flonase Company Summary
7.11.2 Flonase Allergy and Sinus Medicine Business Overview
7.11.3 Flonase Allergy and Sinus Medicine Major Product Offerings
7.11.4 Flonase Allergy and Sinus Medicine Sales and Revenue in Global (2018-2023)
7.11.5 Flonase Key News & Latest Developments
7.12 Benadryl
7.12.1 Benadryl Company Summary
7.12.2 Benadryl Allergy and Sinus Medicine Business Overview
7.12.3 Benadryl Allergy and Sinus Medicine Major Product Offerings
7.12.4 Benadryl Allergy and Sinus Medicine Sales and Revenue in Global (2018-2023)
7.12.5 Benadryl Key News & Latest Developments
7.13 TexaClear
7.13.1 TexaClear Company Summary
7.13.2 TexaClear Allergy and Sinus Medicine Business Overview
7.13.3 TexaClear Allergy and Sinus Medicine Major Product Offerings
7.13.4 TexaClear Allergy and Sinus Medicine Sales and Revenue in Global (2018-2023)
7.13.5 TexaClear Key News & Latest Developments
7.14 Xyzal
7.14.1 Xyzal Company Summary
7.14.2 Xyzal Business Overview
7.14.3 Xyzal Allergy and Sinus Medicine Major Product Offerings
7.14.4 Xyzal Allergy and Sinus Medicine Sales and Revenue in Global (2018-2023)
7.14.5 Xyzal Key News & Latest Developments
7.15 Zyrtec
7.15.1 Zyrtec Company Summary
7.15.2 Zyrtec Business Overview
7.15.3 Zyrtec Allergy and Sinus Medicine Major Product Offerings
7.15.4 Zyrtec Allergy and Sinus Medicine Sales and Revenue in Global (2018-2023)
7.15.5 Zyrtec Key News & Latest Developments
8 Global Allergy and Sinus Medicine Production Capacity, Analysis
8.1 Global Allergy and Sinus Medicine Production Capacity, 2018-2029
8.2 Allergy and Sinus Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Allergy and Sinus Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Allergy and Sinus Medicine Supply Chain Analysis
10.1 Allergy and Sinus Medicine Industry Value Chain
10.2 Allergy and Sinus Medicine Upstream Market
10.3 Allergy and Sinus Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Allergy and Sinus Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Allergy and Sinus Medicine in Global Market
Table 2. Top Allergy and Sinus Medicine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Allergy and Sinus Medicine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Allergy and Sinus Medicine Revenue Share by Companies, 2018-2023
Table 5. Global Allergy and Sinus Medicine Sales by Companies, (K Units), 2018-2023
Table 6. Global Allergy and Sinus Medicine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Allergy and Sinus Medicine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Allergy and Sinus Medicine Product Type
Table 9. List of Global Tier 1 Allergy and Sinus Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Allergy and Sinus Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Allergy and Sinus Medicine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Allergy and Sinus Medicine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Allergy and Sinus Medicine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Allergy and Sinus Medicine Sales (K Units), 2018-2023
Table 15. By Type - Global Allergy and Sinus Medicine Sales (K Units), 2024-2029
Table 16. By Application – Global Allergy and Sinus Medicine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Allergy and Sinus Medicine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Allergy and Sinus Medicine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Allergy and Sinus Medicine Sales (K Units), 2018-2023
Table 20. By Application - Global Allergy and Sinus Medicine Sales (K Units), 2024-2029
Table 21. By Region – Global Allergy and Sinus Medicine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Allergy and Sinus Medicine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Allergy and Sinus Medicine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Allergy and Sinus Medicine Sales (K Units), 2018-2023
Table 25. By Region - Global Allergy and Sinus Medicine Sales (K Units), 2024-2029
Table 26. By Country - North America Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Allergy and Sinus Medicine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Allergy and Sinus Medicine Sales, (K Units), 2018-2023
Table 29. By Country - North America Allergy and Sinus Medicine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Allergy and Sinus Medicine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Allergy and Sinus Medicine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Allergy and Sinus Medicine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Allergy and Sinus Medicine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Allergy and Sinus Medicine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Allergy and Sinus Medicine Sales, (K Units), 2024-2029
Table 38. By Country - South America Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Allergy and Sinus Medicine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Allergy and Sinus Medicine Sales, (K Units), 2018-2023
Table 41. By Country - South America Allergy and Sinus Medicine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Allergy and Sinus Medicine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Allergy and Sinus Medicine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Allergy and Sinus Medicine Sales, (K Units), 2024-2029
Table 46. Libido-Max Company Summary
Table 47. Libido-Max Allergy and Sinus Medicine Product Offerings
Table 48. Libido-Max Allergy and Sinus Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Libido-Max Key News & Latest Developments
Table 50. AZO Company Summary
Table 51. AZO Allergy and Sinus Medicine Product Offerings
Table 52. AZO Allergy and Sinus Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. AZO Key News & Latest Developments
Table 54. Extenze Company Summary
Table 55. Extenze Allergy and Sinus Medicine Product Offerings
Table 56. Extenze Allergy and Sinus Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Extenze Key News & Latest Developments
Table 58. Sudafed Company Summary
Table 59. Sudafed Allergy and Sinus Medicine Product Offerings
Table 60. Sudafed Allergy and Sinus Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Sudafed Key News & Latest Developments
Table 62. Johnson & Johnson (TYLENOL) Company Summary
Table 63. Johnson & Johnson (TYLENOL) Allergy and Sinus Medicine Product Offerings
Table 64. Johnson & Johnson (TYLENOL) Allergy and Sinus Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Johnson & Johnson (TYLENOL) Key News & Latest Developments
Table 66. H-E-B Company Summary
Table 67. H-E-B Allergy and Sinus Medicine Product Offerings
Table 68. H-E-B Allergy and Sinus Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. H-E-B Key News & Latest Developments
Table 70. Breathe Right Company Summary
Table 71. Breathe Right Allergy and Sinus Medicine Product Offerings
Table 72. Breathe Right Allergy and Sinus Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Breathe Right Key News & Latest Developments
Table 74. Kirkland Signature Company Summary
Table 75. Kirkland Signature Allergy and Sinus Medicine Product Offerings
Table 76. Kirkland Signature Allergy and Sinus Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Kirkland Signature Key News & Latest Developments
Table 78. Allegra Company Summary
Table 79. Allegra Allergy and Sinus Medicine Product Offerings
Table 80. Allegra Allergy and Sinus Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Allegra Key News & Latest Developments
Table 82. Claritin Company Summary
Table 83. Claritin Allergy and Sinus Medicine Product Offerings
Table 84. Claritin Allergy and Sinus Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Claritin Key News & Latest Developments
Table 86. Flonase Company Summary
Table 87. Flonase Allergy and Sinus Medicine Product Offerings
Table 88. Flonase Allergy and Sinus Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Flonase Key News & Latest Developments
Table 90. Benadryl Company Summary
Table 91. Benadryl Allergy and Sinus Medicine Product Offerings
Table 92. Benadryl Allergy and Sinus Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Benadryl Key News & Latest Developments
Table 94. TexaClear Company Summary
Table 95. TexaClear Allergy and Sinus Medicine Product Offerings
Table 96. TexaClear Allergy and Sinus Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. TexaClear Key News & Latest Developments
Table 98. Xyzal Company Summary
Table 99. Xyzal Allergy and Sinus Medicine Product Offerings
Table 100. Xyzal Allergy and Sinus Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Xyzal Key News & Latest Developments
Table 102. Zyrtec Company Summary
Table 103. Zyrtec Allergy and Sinus Medicine Product Offerings
Table 104. Zyrtec Allergy and Sinus Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Zyrtec Key News & Latest Developments
Table 106. Allergy and Sinus Medicine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 107. Global Allergy and Sinus Medicine Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Allergy and Sinus Medicine Production by Region, 2018-2023 (K Units)
Table 109. Global Allergy and Sinus Medicine Production by Region, 2024-2029 (K Units)
Table 110. Allergy and Sinus Medicine Market Opportunities & Trends in Global Market
Table 111. Allergy and Sinus Medicine Market Drivers in Global Market
Table 112. Allergy and Sinus Medicine Market Restraints in Global Market
Table 113. Allergy and Sinus Medicine Raw Materials
Table 114. Allergy and Sinus Medicine Raw Materials Suppliers in Global Market
Table 115. Typical Allergy and Sinus Medicine Downstream
Table 116. Allergy and Sinus Medicine Downstream Clients in Global Market
Table 117. Allergy and Sinus Medicine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Allergy and Sinus Medicine Segment by Type in 2022
Figure 2. Allergy and Sinus Medicine Segment by Application in 2022
Figure 3. Global Allergy and Sinus Medicine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Allergy and Sinus Medicine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Allergy and Sinus Medicine Revenue, 2018-2029 (US$, Mn)
Figure 7. Allergy and Sinus Medicine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Allergy and Sinus Medicine Revenue in 2022
Figure 9. By Type - Global Allergy and Sinus Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Allergy and Sinus Medicine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Allergy and Sinus Medicine Sales Market Share, 2018-2029
Figure 12. By Type - Global Allergy and Sinus Medicine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Allergy and Sinus Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Allergy and Sinus Medicine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Allergy and Sinus Medicine Sales Market Share, 2018-2029
Figure 16. By Application - Global Allergy and Sinus Medicine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Allergy and Sinus Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Allergy and Sinus Medicine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Allergy and Sinus Medicine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Allergy and Sinus Medicine Sales Market Share, 2018-2029
Figure 21. By Country - North America Allergy and Sinus Medicine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Allergy and Sinus Medicine Sales Market Share, 2018-2029
Figure 23. US Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Allergy and Sinus Medicine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Allergy and Sinus Medicine Sales Market Share, 2018-2029
Figure 28. Germany Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 29. France Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Allergy and Sinus Medicine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Allergy and Sinus Medicine Sales Market Share, 2018-2029
Figure 37. China Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 41. India Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Allergy and Sinus Medicine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Allergy and Sinus Medicine Sales Market Share, 2018-2029
Figure 44. Brazil Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Allergy and Sinus Medicine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Allergy and Sinus Medicine Sales Market Share, 2018-2029
Figure 48. Turkey Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Allergy and Sinus Medicine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Allergy and Sinus Medicine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Allergy and Sinus Medicine by Region, 2022 VS 2029
Figure 54. Allergy and Sinus Medicine Industry Value Chain
Figure 55. Marketing Channels

※参考情報

アレルギーと副鼻腔炎に関連する薬について、これらの概念や特徴、種類、用途、関連技術について詳しく説明いたします。

アレルギーとは、免疫系が特定の物質、有害とはみなされない物質に対して過剰に反応する現象です。この反応は、例えば花粉、ペットの毛、ダニ、あるいは食品など、様々なアレルゲンによって引き起こされます。アレルギー症状としては、くしゃみ、鼻水、鼻づまり、目のかゆみ、皮膚の発疹などが一般的です。一方、副鼻腔炎は、副鼻腔と呼ばれる顔面にある空洞が炎症を起こす状態を指します。これは、風邪などの感染症やアレルギー反応によって引き起こされることが多く、通常は鼻づまり、痛み、膿のような鼻水、発熱などの症状が伴います。

アレルギーおよび副鼻腔炎の治療に使用される薬剤は多岐にわたります。これらの薬は、症状の緩和、炎症の軽減、またはアレルゲンに対する体の反応を抑制することを目的としています。

代表的なアレルギー治療薬には、抗ヒスタミン薬、クロモグリク酸、ステロイド薬、ロイコトリエン受容体拮抗薬、免疫療法などがあります。抗ヒスタミン薬は、アレルギー反応を引き起こすヒスタミンの作用を抑えることで、くしゃみや鼻水、目のかゆみなどの症状を軽減します。これには、第一世代および第二世代の抗ヒスタミン薬があり、第一世代は眠気を引き起こす可能性が高いのに対し、第二世代はそうした副作用が少ないことが特徴です。

クロモグリク酸は、アレルギー反応の初期段階での炎症を抑える薬で、特に季節性アレルギーやアトピー性皮膚炎に効果があります。この薬は予防的に使用されることが多く、アレルゲンにさらされる前に使用することが推奨されます。

また、ステロイド薬は、強力な抗炎症作用を持ち、特に副鼻腔炎の症状を軽減するのに有効です。これには、局所的に使用される点鼻薬や、全身的に使用される経口薬があります。副作用を考慮し、使用は医師の指示に従うことが重要です。ロイコトリエン受容体拮抗薬は、喘息やアレルギー性鼻炎などの治療に用いられ、気道の炎症を抑制することで呼吸を改善します。

アレルギーや副鼻腔炎の治療における免疫療法は、アレルゲンに対する耐性を獲得することを目的とした治療法で、長期的な改善が期待できる点が特徴です。この治療は、定期的にアレルゲンを少量ずつ摂取することで行われます。時間はかかりますが、根本的な治療を志向する方には有効な方法です。

副鼻腔炎の治療に用いられる薬には、さまざまな外用薬と内服薬があります。副鼻腔の炎症を軽減するために使われるステロイド点鼻薬や抗生物質も一般的です。特に、細菌感染が原因の場合には、抗生物質が非常に重要な役割を果たします。症状が重篤な場合には、手術等の侵襲的治療が選択されることもあります。

現在の技術の進歩により、アレルギー治療はますます効率的に行われるようになっています。例えば、アレルゲン免疫療法などの新しいアプローチが開発され、患者さんにとっての負担が軽減されています。また、モバイルアプリやウェアラブルデバイスを活用して個人のアレルゲンのトラッキングや症状の管理も行われるようになり、患者さん自身の健康管理能力の向上に寄与しています。

さらに、遺伝子治療や再生医療などの研究が進んでおり、未来にはより効果的かつ個別化されたアプローチが期待されています。これにより、アレルギー疾患や副鼻腔炎に悩む多くの人々に福音をもたらすことができるかもしれません。

アレルギー及び副鼻腔炎に関連する薬剤は、さまざまな選択肢と技術の進歩により、これまで以上に効果的な治療が可能となっています。適切な治療を受けることで、患者の生活の質の向上が期待できるでしょう。疾患を正しく理解し、適切な診断と治療を求めることは、アレルギーや副鼻腔炎に対する最良の防御策と言えます。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ アレルギー&副鼻腔炎薬の世界市場見通し2023年-2029年(Allergy and Sinus Medicine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

アレルギー&副鼻腔炎薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp